Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age5-25
SponsorCairo University
About this trial
This study will compare the efficacy and safety of crisaborole ointment with tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis.
Eligibility criteria
Qualifiers
Patients with diagnosis of AD, according to Hanifin and Rajka criteria.
Patients of both genders
Age 5-25 years
Baseline Investigator's Static Global Assessment (ISGA) score of mild (2) or moderate (3).
Disqualifiers
Clinically infected eczema.
Baseline Investigator's Static Global Assessment (ISGA) score of severe (4).
Associated comorbidities that exacerbate pruritus.
Patients receiving topical treatment for AD and/or pruritus within the past 14 days and/or systemic treatment within the past month.
Trial design
Treatments tested in this trial
- Application of crisaborole twice daily
- Tacrolimus ointment in atopic dermatitis
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov